Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 9/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.70 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | MLYCD | O95822 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | CA12 | O43570 | 2/20 | 0.53 |
| ▸ | CA1 | P00915 | 2/20 | 0.53 |
| ▸ | CA2 | P00918 | 2/20 | 0.53 |
| ▸ | CA7 | P43166 | 2/20 | 0.53 |
| ▸ | CA9 | Q16790 | 2/20 | 0.53 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.51 |
| ▸ | L3MBTL3 | Q96JM7 | 3/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.51 |
| ▸ | MBTD1 | Q05BQ5 | 1/20 | 0.51 |
| ▸ | TP53BP1 | Q12888 | 1/20 | 0.51 |
| ▸ | L3MBTL4 | Q8NA19 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL258027 | 0.98 | HPGD (0.74) | HPGDALDH1A1MAPK1MLYCDLMNA | |
| SCHEMBL950365 | 0.96 | HPGD (0.64) | HPGDALDH1A1MAPK1MLYCDLMNA | |
| SCHEMBL29950978 | 0.92 | HPGD (0.57) | HPGDALDH1A1MAPK1LMNAMEN1 | |
| SCHEMBL28890427 | 0.90 | HPGD (0.58) | HPGDALDH1A1MAPK1MLYCDLMNA | |
| SCHEMBL10721733 | 0.85 | HPGD (0.95) | HPGDALDH1A1MAPK1MLYCDLMNA | |
| SCHEMBL109091 | 0.84 | PHGDH (0.65) | HPGDALDH1A1MAPK1MLYCDTSHR | |
| SCHEMBL29956781 | 0.84 | HPGD (0.65) | HPGDALDH1A1MAPK1MLYCDLMNA | |
| SCHEMBL532147 | 0.84 | POLB (0.65) | HPGDLMNAMEN1TSHRKMT2A | |
| SCHEMBL1951522 | 0.84 | SIGMAR1 (0.64) | HPGDALDH1A1L3MBTL1L3MBTL3 | |
| SCHEMBL1490905 | 0.84 | HPGD (0.48) | HPGDALDH1A1MAPK1MLYCDLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 208 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250194617-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2025-06-19 | — | — | US | claimed |
| US-20250169514-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2025-05-29 | — | — | US | claimed |
| EP-4280882-A2 | MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS | JP LABORATORIES, INC. (US) | 2023-11-29 | — | — | EP | claimed |
| WO-2022159439-A2 | MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS | JP LABORATORIES, INC. (US) | 2022-07-28 | — | — | WO | claimed |
| EP-2718265-B1 | PROCESS FOR PREPARING [(3-HYDROXYPYRIDINE-2-CARBONYL)AMINO]ALKANOIC ACIDS, ESTERS AND AMIDES | AKEBIA THERAPEUTICS INC (US) | 2015-12-16 | — | — | EP | claimed |
| EP-2940009-A1 | METHODS OF SYNTHESIS OF BENZAZEPINE DERIVATIVES | VentiRx Pharmaceuticals, Inc. (US) | 2015-11-04 | — | — | EP | claimed |
| US-9145366-B2 | Process for preparing [(3-hydroxypyridine-2-carbonyl)amino]alkanoic acids, esters and amides | AKEBIA THERAPEUTICS, INC. (US) | 2015-09-29 | — | — | US | claimed |
| EP-2358683-B1 | METHODS OF SYNTHESIS OF BENZAZEPINE DERIVATIVES | VENTIRX PHARMACEUTICALS INC (US) | 2015-04-01 | — | — | EP | claimed |
| EP-2718265-A1 | PROCESS FOR PREPARING [(3-HYDROXYPYRIDINE-2-CARBONYL)AMINO]ALKANOIC ACIDS, ESTERS AND AMIDES | Akebia Therapeutics Inc. (US) | 2014-04-16 | — | — | EP | claimed |
| WO-2012170377-A1 | PROCESS FOR PREPARING [(3-HYDROXYPYRIDINE-2-CARBONYL)AMINO]ALKANOIC ACIDS, ESTERS AND AMIDES | AKEBIA THERAPEUTICS INC. (US) | 2012-12-13 | — | — | WO | claimed |
| US-20120309977-A1 | PROCESS FOR PREPARING [(3-HYDROXYPYRIDINE-2-CARBONYL)AMINO]ALKANOIC ACIDS, ESTERS AND AMIDES | AKEBIA THERAPEUTICS INC. (US) | 2012-12-06 | — | — | US | claimed |
| US-8314090-B2 | Methods of synthesis of benzazepine derivatives | VENTIRX PHARMACEUTICALS, INC. (US) | 2012-11-20 | — | — | US | claimed |
| EP-2358683-A1 | METHODS OF SYNTHESIS OF BENZAZEPINE DERIVATIVES | Ventirx Pharmaceuticals, Inc. (US) | 2011-08-24 | — | — | EP | claimed |
| US-20100216989-A1 | METHODS OF SYNTHESIS OF BENZAZEPINE DERIVATIVES | VENTIRX PHARMACEUTICALS, INC. (US) | 2010-08-26 | — | — | US | claimed |
| WO-2010054215-A1 | METHODS OF SYNTHESIS OF BENZAZEPINE DERIVATIVES | VENTIRX PHARMACEUTICALS, INC. (US) | 2010-05-14 | — | — | WO | claimed |
| EP-4306529-B1 | FGFR INHIBITORS AND METHODS OF USE THEREOF | RELAY THERAPEUTICS INC (US) | 2026-01-21 | — | — | EP | disclosed |
| US-12522605-B2 | FGFR inhibitors and methods of use thereof | RELAY THERAPEUTICS, INC. (US) | 2026-01-13 | — | — | US | disclosed |
| US-20060019959-A1 | Novel quinoxalinone derivatives | BANYU PHARMACEUTICAL CO., LTD. TSUKUBA RESEARCH INSTITUTE (JP) | 2006-01-26 | — | — | US | disclosed |
| WO-2006001754-A1 | NEW DERIVATIVES OF 5-ARYL-1H-PYRROLO [2, 3B] PYRIDINE-3-CARBOXAMIDE OR 5-ARYL-1H-PYRROLO [2, 3B] PYRIDINE-3-CARBOXYLIC ACID | ASTRAZENECA AB (SE) | 2006-01-05 | — | — | WO | disclosed |
| EP-1557418-A1 | NOVEL QUINOXALINE DERIVATIVES | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2005-07-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100216989-A1 | METHODS OF SYNTHESIS OF BENZAZEPINE DERIVATIVES | MAOB, GABBR1, HNMT | HPGD 2138/4885ALDH1A1 536/4885MAPK1 4102/4885 |
| US-20120309977-A1 | PROCESS FOR PREPARING [(3-HYDROXYPYRIDINE-2-CARBONYL)AMINO]ALKANOIC ACIDS, ESTERS AND AMIDES | HPD, APEH, ALDH7A1 | HPGD 41/4885ALDH1A1 36/4885MAPK1 3424/4885 |
| US-20060019959-A1 | Novel quinoxalinone derivatives | NDUFB1, NDUFB6, NDUFB11 | HPGD 201/4885ALDH1A1 1279/4885MAPK1 642/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.